Pharmacokinetics of oral ibuprofen in premature infants

Journal of Clinical Pharmacology

Volumn 43, Issue 9, 2003, Pages 968-973

  Sharma, Pramod Kumar ^a   Garg, Santosh Kumar ^a   Narang, Anil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Oral ibuprofen; Patent ductus arteriosus; Pediatrics; Pharmacokinetics; Premature infants

Indexed keywords

IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

AREA UNDER THE CURVE; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GENDER; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; SIDE EFFECT; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; MALE; SEX FACTORS;

EID: 0041511704     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003254635     Document Type: Article

References (29)

1. Clyman RI: Medical treatment of patent ductus arteriosus in premature infants, in: Long WA (ed.), Fetal and Neonatal Cardiology. Philadelphia: W. B. Saunders, 1990;682-690.
2. Auld PAM: Delayed closure of the ductus arteriosus. J Pediatr 1966;69:61-66.
3. Alpert BS, Lewins MJ, Rowland DW, Grant MJ, Olley PM, Soldin SJ, et al: Plasma indomethacin levels in newborns with patent ductus. Pediatr Res 1979;13:399.
4. Bhat R, Vidyasagar D, Vadapalli M, Whalley C, Fisher E, Hastreiter A, et al: Disposition of indomethacin in preterm infants, J Pediatr 1979;95;313-316.
5. Yanagi R, Aziz K, Hunt CE: Efficacy of indomethacin for symptomatic PDA: a double blind control study [abstract]. Pediatr Res 1979;13:354.
6. Friedman WF, Fitzpatrick KM, Menitt TA, Feldman BH: The patent ductus arteriosus. Clin Perinatol 1978;5:411-436.
7. Halliday HL, Hirata T, Brady JP: Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infants: results and complications. Pediatrics 1979;64:154-159.
8. Yeh TF, Thalji A, Luken J, Raval D, Carr I, Pilders RS: Intravenous indocin therapy in premature infants with PDA: a double blind control study [abstract]. Pediatr Res 1979;13:354.
9. Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS: Indomethacin and its effects on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981; 68:99-102.
10. Rennie JM, Doyle J, Cooke RW: Early administration of indomethacin to preterm infants. Arch Dis Child 1986;61:233-238.
11. Mitchell JA, Alcarasereenont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclo-oxygenase. Proc Natl Acad Sci USA 1993;90:11693-11697.
12. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV: Changes in cerebrovascular prostaglandins and thromboxane as a function of systemic blood pressure: cerebral blood flow autoregulation of the newborn. Circ Res 1990;67:674-682.
13. Coceani F, White E, Bodach E, Olley PM: Age dependent changes in the response of lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol 1979;57:825-831.
14. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV: Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-544.
15. Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin C, Modanlou H, et al: Pharmacokinetics and protein binding of intravenous ibuprofen in the newborn infants. Acta Pediatr 1997;86:289-293.
16. Van Overmeire B, Touw D, Schepens PJC, Kearns GL, van den Anker JN: Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001;70:336-343.
17. Garg SK, Chakrabarti A, Lal R, Kumar N, Sharma PL: Measurement of plasma ibuprofen concentration by high performance liquid chromatography. PGI Bull 1988;22:217-222.
18. Kelly MT, Walson PD, Edge JH, Cox S, Mortensen ME: Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther 1992;52: 181-189.
19. Kauffman RE, Nelson MV: Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr 1992;121:969-973.
20. Martin W, Koselowske G, Toberich H, Kerkmann TH, Mangold B, Augustin J: Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man. Biopharm Drug Disp 1990;11:265-278.
21. Gal P, Ransom JL, Schall S, Weaver RL, Bird A, Brown Y: Indomethacin for patent ductus arteriosus closure: application of serum concentrations and pharmacodynamics to improve response. J Perinatol 1990;10:20-26.
22. Touw DJ: Clinical implications of genetic polymorphism and drug interactions mediated by cytochrome P-450 enzymes. Drug Metab Drug Interact 1997;14:55-82.
23. Hamman MA, Thompson GA, Hall SD: Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochem Pharmacol 1997;54:33-41.
24. Gal P, Gilman JT: Drug disposition in neonates with patent ductus arteriosus. Ann Pharmacother 1993;27:1383-1388.
25. Watterberg KL, Kelly HW, Jhonson JD, Aldrich M, Angelus P: Effect of patent ductus arteriosus on gentamicin pharmacokinetics in very low birth weight (less than 1500 g) babies. Dev Pharmacol Ther 1987;10:107-117.
26. Williams BS, Ransom JL, Gal P, Carlos RQ, Smith M, Schell SA: Gentamicin pharmacokinetics in neonates with patent ductus arteriosus. Crit Care Med 1997;25:372-375.
27. Gal P, Ransom JL, Weaver RL, Schall S, Wyble LE, Carlos RQ, et al: Indomethacin pharmacokinetics in neonates: the value of volume of distribution as a marker of patent ductus arteriosus closure. Ther Drug Monit 1991;13:42-45.
28. Thalji AA, Carr I, Yeh TF, Raval D, Luken JA, Phildes RS: Pharmacokinetics of intravenously administered indomethacin in premature infants. J Pediatr 1980;97:995-1000.
29. Touw DJ, Stevens R, Gianotten E, Roord JJ, Lafeber HN, Van Weissenbruch MM: Gentamicin pharmacokinetics in preterm infants with a patent ductus arteriosus [abstract A57]. Paper presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24-27, 1998.